OptimizeRx (OPRX) EBITDA (2010 - 2026)
OptimizeRx (OPRX) EBITDA from Jun 30, 2010 to Mar 31, 2026. The TTM OptimizeRx (OPRX) EBITDA is $18M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
OptimizeRx (OPRX) EBITDA CAGR table
| Period | CAGR |
|---|---|
| 5 Years TTM | +77.82% |
Annual EBITDA change of OptimizeRx (OPRX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | $1.46M | -90.89% |
| 2025 | $16M | -270.79% |
| 2024 | -$9.38M | -60.92% |
| 2023 | -$24M | +133.69% |
| 2022 | -$10M | -540.77% |
| 2021 | $2.33M | -3983.33% |
| 2020 | -$60K | -97.51% |
| 2019 | -$2.41M | -582.00% |
| 2018 | $500K | -127.62% |
| 2017 | -$1.81M | +34.07% |
| 2016 | -$1.35M | +419.23% |
| 2015 | -$260K | -65.79% |
| 2014 | -$760K | +985.71% |
| 2013 | -$70K | -74.07% |
| 2012 | -$270K | -79.39% |
| 2011 | -$1.31M | -26.82% |
| 2010 | -$1.79M | N/A |
Comparison OptimizeRx (OPRX) five years EBITDA CAGR with competitors
OptimizeRx (OPRX) five years EBITDA CAGR is 77.72%.
| Ticker | Name | five years EBITDA CAGR | Upside |
|---|---|---|---|
| CCLD | CareCloud Inc | 73.90% | -4.92% |
| CCLDO | CareCloud Inc | 73.90% | -4.92% |
| SY | So-Young International Inc | 39.98% | -48.56% |
| DOCS | Doximity Inc - Class A | 32.10% | -58.70% |
| HQY | Healthequity Inc | 26.05% | -66.48% |
| VEEV | Veeva Systems Inc - Class A | 25.30% | -67.45% |
| HCAT | Health Catalyst Inc | 20.13% | -74.09% |
| SDGR | Schrodinger Inc | 18.03% | -76.80% |
| PRVA | Privia Health Group Inc | 10.68% | -86.26% |
| EVH | Evolent Health Inc - Class A | 9.64% | -87.60% |
| SOPH | SOPHiA Genetics SA | 9.33% | -88.00% |
| HSTM | Healthstream Inc | 9.04% | -88.37% |
| OMCL | Omnicell Inc | 0.63% | -99.19% |
| DRIO | DarioHealth Corp | 0.22% | -99.72% |